Health Condition 1: H357- Separation of retinal layers
Conditions
Interventions
Intervention1: 532 nm laser: 532-nm subthreshold micropulse laser with the following laser settings will be used: power 30% of threshold power after titration
200â??ms duration
5% duty cycle
and slit lamp (aerial) spot size of 100â??μm. Area centralis contact lens will be used to deliver the laser in a confluent fashion to the focal area of leakage seen on FFA.
Control Intervention1: 810
and slit lamp (aerial) spot size of 100â??μm. Area centralis contact lens will be used to deliver the laser in a confluent fashion to the focal area of leakage seen on FFA.
Sponsors
Armed Forces Medical Research Cell
Armed Forces Medical Research Cell
Eligibility
Inclusion criteria
Inclusion criteria: (i) Vision loss for a duration of minimum 3 months due to persistent CSC (ii) Focal leaks (upto two leaks) on fundus fluorescein angiography (FFA).
Exclusion criteria
Exclusion criteria: (1) chronic CSCR characterized by RPE atrophy, diffuse leak on FFA; (2) history of treatment for CSCR in the past; (3) multiple leaks on FFA; (4) any other vitreoretinal disorder currently or in the past; (5) any intraocular procedure in the past 6 months; (6) systemic or topical steroid therapy currently/ in the past 6 months; (7) presence of opaque media likely to affect quality of imaging; (8) spherical equivalent ⩾± 6D.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Resolution of subretinal fluid.Timepoint: 1 month, 3 months and 6 months after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| (i) To compare the functional outcome of the treatment assessed by best corrected visual acuity (BCVA). (ii) To report any ocular adverse effect in either treatment arm. Timepoint: 1,2,3, and 6 months | — |
Countries
India
Contacts
Public ContactVikas Ambiya
Command Hospital, Alipore Road, Kolkata
Outcome results
None listed